CAPTOPRIL AND HYDROCHLOROTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
When do Captopril And Hydrochlorothiazide patents expire, and when can generic versions of Captopril And Hydrochlorothiazide launch?
Captopril And Hydrochlorothiazide is a drug marketed by Cosette, Ivax Sub Teva Pharms, Rising, Strides Pharma, and Watson Labs. and is included in five NDAs.
The generic ingredient in CAPTOPRIL AND HYDROCHLOROTHIAZIDE is captopril; hydrochlorothiazide. There are fifteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the captopril; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Captopril And Hydrochlorothiazide
A generic version of CAPTOPRIL AND HYDROCHLOROTHIAZIDE was approved as captopril; hydrochlorothiazide by RISING on December 29th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CAPTOPRIL AND HYDROCHLOROTHIAZIDE?
- What are the global sales for CAPTOPRIL AND HYDROCHLOROTHIAZIDE?
- What is Average Wholesale Price for CAPTOPRIL AND HYDROCHLOROTHIAZIDE?
Summary for CAPTOPRIL AND HYDROCHLOROTHIAZIDE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 13 |
| Clinical Trials: | 4 |
| Patent Applications: | 9 |
| DailyMed Link: | CAPTOPRIL AND HYDROCHLOROTHIAZIDE at DailyMed |
Recent Clinical Trials for CAPTOPRIL AND HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| GlaxoSmithKline | Phase 1 |
| West China Hospital | Phase 4 |
| Vanderbilt University Medical Center | Phase 1 |
Pharmacology for CAPTOPRIL AND HYDROCHLOROTHIAZIDE
| Drug Class | Angiotensin Converting Enzyme Inhibitor Thiazide Diuretic |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
| Physiological Effect | Increased Diuresis |
US Patents and Regulatory Information for CAPTOPRIL AND HYDROCHLOROTHIAZIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cosette | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | captopril; hydrochlorothiazide | TABLET;ORAL | 074827-001 | Dec 29, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ivax Sub Teva Pharms | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | captopril; hydrochlorothiazide | TABLET;ORAL | 075055-004 | Jun 18, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cosette | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | captopril; hydrochlorothiazide | TABLET;ORAL | 074827-003 | Dec 29, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
